Delivery Order SPE2DB22D2007-SPE2DB24FJ4QE
Award Date
7/29/24
Potential Completion Date
8/19/24
Potential Value
$100K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $24,963.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, and has an ultimate completion date of October 3, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $41,399.91, is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, to support military treatment programs and facilities. This contract is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, worth $20,562.98, is for the delivery of REVLIMID 25 MG CAPSULE 21S, a specialty pharmaceutical product. The contract has an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4564060034 REVLIMID 10 MG CAPSULE 28S. The contract has a ceiling value of $13,929.89 and a performance period through April 12, 2024. This delivery order is issued under Amerisourcebergen's pre-existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $49,926.80. The order is for REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of October 9, 2024 and is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $178,310.12, is for the supply of REVLIMID 5 MG CAPSULE 100S, a medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide REVLIMID 10 MG CAPSULE 28S. This $55,719.56 contract has a completion date of March 19, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This award is not associated with any set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $27,859.78, is for the delivery of REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product, with a performance period through April 3, 2024. This delivery order is issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp...
The U.S. government awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REVLIMID 10 MG CAPSULE 100S. The contract, valued at $105,150.98, has an ultimate completion date of July 14, 2025 and was awarded on June 20, 2025. The contract is funded by the Defense Logistics Agency (DLA), a defense agency. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $89,155.06, is for the delivery of REVLIMID 5 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 7, 2025. The contract was awarded on February 13, 2025 and does not have a set-aside designation,...